InBody Co.Ltd
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly known as Biospace Co., Ltd. InBody Co.,Ltd was foun… Read more
Market Cap & Net Worth: InBody Co.Ltd (041830)
InBody Co.Ltd (KQ:041830) has a market capitalization of $269.34 Million (₩394.37 Billion) as of March 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #14834 globally and #425 in its home market, demonstrating a 2.45% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying InBody Co.Ltd's stock price ₩29250.00 by its total outstanding shares 13482600 (13.48 Million).
InBody Co.Ltd Market Cap History: 2015 to 2026
InBody Co.Ltd's market capitalization history from 2015 to 2026. Data shows change from $501.57 Million to $269.34 Million (-2.39% CAGR).
Index Memberships
InBody Co.Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.85 Billion | 0.12% | #151 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.85 Billion | 0.12% | #151 of 1384 |
Weight: InBody Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
InBody Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how InBody Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
InBody Co.Ltd's market cap is 0.00 times its annual revenue
0.08x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.01x
InBody Co.Ltd's market cap is 0.01 times its annual earnings
0.00x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $501.57 Million | $68.95 Billion | $17.31 Billion | 0.01x | 0.03x |
| 2016 | $234.42 Million | $79.85 Billion | $16.99 Billion | 0.00x | 0.01x |
| 2017 | $349.23 Million | $93.25 Billion | $19.32 Billion | 0.00x | 0.02x |
| 2018 | $190.07 Million | $99.64 Billion | $19.67 Billion | 0.00x | 0.01x |
| 2019 | $208.39 Million | $117.06 Billion | $20.43 Billion | 0.00x | 0.01x |
| 2020 | $154.16 Million | $107.12 Billion | $17.52 Billion | 0.00x | 0.01x |
| 2021 | $207.54 Million | $137.84 Billion | $34.03 Billion | 0.00x | 0.01x |
| 2022 | $183.86 Million | $160.00 Billion | $33.82 Billion | 0.00x | 0.01x |
| 2023 | $233.43 Million | $170.35 Billion | $36.72 Billion | 0.00x | 0.01x |
| 2024 | $213.63 Million | $204.46 Billion | $33.14 Billion | 0.00x | 0.01x |
Competitor Companies of 041830 by Market Capitalization
Companies near InBody Co.Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to InBody Co.Ltd by market ranking:
- i-SENS Inc (KQ:099190): Ranked #17199 globally with a market cap of $127.37 Million USD ( ₩186.50 Billion KRW).
- Value Added Technology Co. Ltd (KQ:043150): Ranked #17851 globally with a market cap of $109.99 Million USD ( ₩161.04 Billion KRW).
- MEDIANA Co.Ltd (KQ:041920): Ranked #19669 globally with a market cap of $70.69 Million USD ( ₩103.51 Billion KRW).
- INFINITT Healthcare Co. Ltd (KQ:071200): Ranked #20964 globally with a market cap of $53.10 Million USD ( ₩77.75 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #17199 | i-SENS Inc | KQ:099190 | $127.37 Million | ₩21000.00 |
| #17851 | Value Added Technology Co. Ltd | KQ:043150 | $109.99 Million | ₩23350.00 |
| #19669 | MEDIANA Co.Ltd | KQ:041920 | $70.69 Million | ₩19690.00 |
| #20964 | INFINITT Healthcare Co. Ltd | KQ:071200 | $53.10 Million | ₩5860.00 |
InBody Co.Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, InBody Co.Ltd's market cap moved from $501.57 Million to $ 269.34 Million, with a yearly change of -2.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩269.34 Million | -10.69% |
| 2025 | ₩301.57 Million | +41.16% |
| 2024 | ₩213.63 Million | -8.48% |
| 2023 | ₩233.43 Million | +26.96% |
| 2022 | ₩183.86 Million | -11.41% |
| 2021 | ₩207.54 Million | +34.62% |
| 2020 | ₩154.16 Million | -26.02% |
| 2019 | ₩208.39 Million | +9.64% |
| 2018 | ₩190.07 Million | -45.58% |
| 2017 | ₩349.23 Million | +48.98% |
| 2016 | ₩234.42 Million | -53.26% |
| 2015 | ₩501.57 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of InBody Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $269.34 Million USD |
| MoneyControl | $269.34 Million USD |
| MarketWatch | $269.34 Million USD |
| marketcap.company | $269.34 Million USD |
| Reuters | $269.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.